|
A simple
test may help identify kidney transplant recipients who are at
higher risk of rejecting their newly transplanted organ, according
to Stanford School of Medicine researchers.
In a study
involving 60 children who received kidney transplants, the researchers
used DNA microarrays to examine gene patterns in biopsy samples
taken from transplanted organs that were functioning normally
andfrom organs that had gone into rejection.
They reported
in the New England Journal of Medicine that they were able to
divide episodes of acute rejection into at least three subgroups.
In one of
the three subgroups associated with particularly poor outcomes,
the researchers ultimately identified clusters of B cells -- a
type of immune cell previously not thought to play a significant
role in rejection.
"The
presence of dense clusters of B cells in a biopsy sample was strongly
associated with severe graft rejection, suggesting a pivotal role
of infiltrating B cells in acute rejection," the researchers
concluded.
Dr. Minnie
Sarwal, who led the study, said that if researchers can go on
to figure out which of the more serious rejections are due to
these B cells, they can perhaps use antibodies to specifically
wipe out B cells in these transplant recipients.
Other
Sources: New
England Journal of Medicine
|